Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases

References

• Zippi M, Pica R, De Nitto D, Paoluzi P. Biological therapy for dermatological manifestations of inflammatory bowel disease. World J Clin Cases. 2013;1:74–8.
   PubMedGoogle Scholar
• Atzeni F, Ardizzone S, Bertani L, Antivalle M, Batticciotto A, Sarzi-Puttini P. Combined therapeutic approach: inflammatory bowel diseases and peripheral or axial arthritis. World J Gastroenterol. 2009;15:2469–71.
   PubMed Web of Science ®Google Scholar
• Stolwijk C, Pierik M, Landewé R, Masclee A, van Tubergen A. Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease. Can J Gastroenterol. 2013;27:199–205.
   PubMed Web of Science ®Google Scholar
• Sheth T, Pitchumoni CS, Das KM. Musculoskeletal manifestations in inflammatory bowel disease: a revisit in search of immunopathophysiological mechanisms. J Clin Gastroenterol. 2014;48:308–17.
   PubMed Web of Science ®Google Scholar
• Ardizzone S, Sarzi Puttini P, Cassinotti A, Bianchi Porro G. Extraintestinal manifestations of inflammatory bowel disease. Digest Liver Dis. 2008;40S:S253–S9.
   Google Scholar
• Horton DB, Sherry DD, Baldassano RN, Weiss PF. Enthesitis is an extraintestinal manifestation of pediatric. Inflammatory bowel disease. Ann Paediatr Rheumatol. 2012;1. doi:10.5455/apr.102920121510.
   PubMedGoogle Scholar
• Turkcapar N, Toruner M, Soykan I, Aydintug OT, Cetinkaya H, Duzgun N, et al. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatol Int. 2006;26:663–8.
   PubMed Web of Science ®Google Scholar
• Serra I, Oller B, Mañosa M, Naves JE, Zabana Y, Cabré E, Domènech E. Systemic amyloidosis in inflammatory bowel disease: retrospective study on its prevalence, clinical presentation, and outcome. J Crohns Colitis. 2010;4:269–74.
   PubMed Web of Science ®Google Scholar
• Bernstein CN. Osteoporosis and other complications of inflammatory bowel disease. Curr Opin Gastroenterol. 2002;18:428–34.
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med. 2000;133:795–9.
   PubMed Web of Science ®Google Scholar
• Cruz VA, Yamaguchi L, Ribeiro CN, Magalhães Vde O, Rego J, Silva NA. Ulcerative colitis and rheumatoid arthritis: a rare association – case report. Rev Bras Reumatol. 2012;52:648–50.
   PubMed Web of Science ®Google Scholar
• Georgiadis AN, Tzambouras N, Ioachim E, Tsianos EV, Agnantis N, Drosos AA. Seropositive rheumatoid arthritis associated with Crohn’s disease. Clin Exp Rheumatol. 2003;21:363–5.
   PubMed Web of Science ®Google Scholar
• Stather P, Cheshire H. Fistulating Crohn’s disease in a patient with rheumatoid arthritis. J Crohns Colitis. 2010;4:347.
   PubMed Web of Science ®Google Scholar
• Naves JE, Cabré E, Mañosa M, Grados D, Olivé A, Domènech E. A systematic review of SAPHO syndrome and inflammatory bowel disease association. Dig Dis Sci. 2013;58:2138–47.
   PubMed Web of Science ®Google Scholar
• Kono M, Oshitani N, Sawa Y, Watanabe K, Kamata N, Oiso R, et al. Crohn’s disease complicated by adult-onset Still’s disease. J Gastroenterol. 2003;38:891–5.
   PubMed Web of Science ®Google Scholar
• Rajabally MN, Watermeyer GA, Levin DA. A case of Crohn’s disease complicated by adult onset Still’s disease. J Crohns Colitis. 2010;4:475–8.
   PubMed Web of Science ®Google Scholar
• Katsanos KH, Siozopoulou V, Sigounas D, Tsianos VE, Christodoulou D, Mitsi V, Tsianos EV. Adult-onset Still’s disease preceding Crohn’s disease. J Crohn’s Colitis. 2013;7:e93–8.
   Google Scholar
• Moravvej H, Razavi GM, Farshchian M, Malekzadeh R. Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study. Indian J Dermatol Venereol Leprol. 2008;74:607–10.
   PubMed Web of Science ®Google Scholar
• Chapman RS, Forsyth A, MacQueen A. Erythema multiforme in association with active ulcerative colitis and Crohn’s disease. Dermatologica. 1977;154:32–8.
   PubMedGoogle Scholar
• Ytting H, Vind I, Bang D, Munkholm P. Sweet’s syndrome an extraintestinal manifestation in inflammatory bowel disease. Digestion. 2005;72:195–200.
   PubMed Web of Science ®Google Scholar
• Moran GW, Lim AWK, Bailey JL, Dubeau MF, Leung Y, Devlin SM, et al. Dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38:1002–24.
   PubMed Web of Science ®Google Scholar
• Ahmad I, Owens D. Granulomatous cheilitis and Crohn’s disease. Can J Gastroenterol. 2001;15:273–5.
   PubMed Web of Science ®Google Scholar
• Sigl I, Bauerdorf R. Granulomatous rosacea associated with ulcerative colitis: 2 case reports. Z Hautkr. 1989;64:499–502.
   PubMedGoogle Scholar
• Andreani SM, Ratnasingham K, Dang HH, Gravante G, Giordano P. Crohn’s disease of the vulva. Int J Surg. 2010;8:2–5.
   PubMed Web of Science ®Google Scholar
• Scheinfeld N. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis. Dermatol Online J. 2013;19:18558.
   PubMedGoogle Scholar
• Safina DD, Abdulkhakov RA, Abdulkhakov SR, Odintsova AKh, Cheremina NA. Clinical case of a combination of ulcerative colitis and alopecia areata. Eksp Klin Gastroenterol. 2013;12:92–6.
   PubMedGoogle Scholar
• Du Boulay C, Whorwell PJ. ‘Nodular necrobiosis’: a new cutaneous manifestation of Crohn’s disease? Gut. 1982;23:712–15.
   PubMed Web of Science ®Google Scholar
• Li WQ, Han JL, Chan AT, Qureshi AA. Psoriasis, psoriatic arthritis and increased risk of incident Crohn’s disease in US women. Ann Rheum Dis. 2013;72:1200–5.
   PubMed Web of Science ®Google Scholar
• Barthel C, Biedermann L, Frei P, Vavricka SR, Kündig T, Fried M, et al. Induction or exacerbation of psoriasis in patients with Crohn’s disease under treatment with anti-TNF antibodies. Digestion. 2014;89:209–15.
   PubMed Web of Science ®Google Scholar
• Chaoui Z, Bernoussi A, Belmekki M, Berraho A. Uveitis and chronic intestinal inflammatory diseases: three case studies. J Fr Ophtalmol. 2005;28:854–6.
   PubMed Web of Science ®Google Scholar
• Culver EL, Salmon JF, Frith P, Travis SP. Recurrent posterior scleritis and orbital myositis as extra-intestinal manifestations of Crohn’s disease: case report and systematic literature review. J Crohns Colitis. 2008;2:337–42.
   PubMed Web of Science ®Google Scholar
• Cury DB, Moss AC. Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:1393–6.
   PubMed Web of Science ®Google Scholar
• Ji XQ, Wang LX, Lu DG. Pulmonary manifestations of inflammatory bowel disease. World J Gastroenterol. 2014;20:13501–11.
   PubMed Web of Science ®Google Scholar
• Alrashid AI, Brown RD, Mihalov ML, Sekosan M, Pastika BJ, Venu RP, Crohn’s D. Crohn’s disease involving the lung: resolution with infliximab. Dig Dis Sci. 2001;46:1736–9.
   PubMed Web of Science ®Google Scholar
• Basseri B, Enayati P, Marchevsky A, Papadakis KA. Pulmonary manifestations of inflammatory bowel disease: case presentations and review. J Crohns Colitis. 2010;4:390–7.
   PubMed Web of Science ®Google Scholar
• Oikonomou K, Kapsoritakis A, Eleftheriadis T, Stefanidis I, Potamianos S. Renal manifestations and complications of inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:1034–45.
   PubMed Web of Science ®Google Scholar
• Bambach CP, Robertson WG, Peacock M, Hill GL. Effect of intestinal surgery on the risk of urinary stone formation. Gut. 1981;22:257–63.
   PubMed Web of Science ®Google Scholar
• Cury DB, Moss AC, Schor N. Nephrolithiasis in patients with inflammatory bowel disease in the community. Int J Nephrol Renovasc Dis. 2013;6:139–42.
   PubMedGoogle Scholar
• Primas C, Novacek G, Schweiger K, Mayer A, Eser A, Papay P, et al. Renal insufficiency in IBD-prevalence and possible pathogenetic aspects. J Crohns Colitis. 2013;7:e630–4.
   Google Scholar
• Shaaban H, Maroules M. A rare case of gastric Crohn’s disease associated with immune thrombocytopenic purpura. J Crohns Colitis. 2013;7:e401–2.
   Google Scholar
• Guagnozzi D, Lucendo AJ. Anemia in inflammatory bowel disease: a neglected issue with relevant effects. World J Gastroenterol. 2014;20:3542–51.
   PubMed Web of Science ®Google Scholar
• Rellecke P, Strauer BE. Chronic inflammatory bowel disease and cardiovascular complications. Med Klin (Munich). 2006;101:56–60.
   PubMedGoogle Scholar
• Fumery M, Xiaocang C, Dauchet L, Gower-Rousseau C, Peyrin-Biroulet L, Colombel J. Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. J Crohns Colitis. 2014;8:469–79.
   PubMed Web of Science ®Google Scholar
• Martinović Z, Perisić K, Pejnović N, Lukacević S, Rabrenović L, Petrović M. Antiphospholipid antibodies in inflammatory bowel diseases. Vojnosanit Pregl. 1998;55:47–9.
   PubMedGoogle Scholar
• Zezos P, Kouklakis G, Saibil F. Inflammatory bowel disease and thromboembolism. World J Gastroenterol. 2014;20:13863–78.
   PubMed Web of Science ®Google Scholar
• Casella G, Tontini GE, Bassotti G, Pastorelli L, Villanacci V, Spina L, et al. Neurological disorders and inflammatory bowel diseases. World J Gastroenterol. 2014;20:8764–82.
   PubMed Web of Science ®Google Scholar
• Geissler A, Andus T, Roth M, Kullmann F, Caesar I, Held P, et al. Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet. 1995;345:897–8.
   PubMed Web of Science ®Google Scholar
• Karajeh MA, Hadjivassiliou M, Hurlstone P, Grundman MJ. Neurological sequelae of Crohn’s disease: opportunity to study common etiological pathways. J Gastroenterol Hepaol. 2004;1093–4.
   PubMed Web of Science ®Google Scholar
• Rojas-Feria M, Castro M, Suárez E, Ampuero J, Romero-Gómez M. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver. World J Gastroenterol. 2013;19:7327–40.
   PubMed Web of Science ®Google Scholar
• Dastis SN, Latinne D, Sempoux C, Geubel AP. Ulcerative colitis associated with IgG4 cholangitis: similar features in two HLA identical siblings. J Hepatol. 2009;51:601–5.
   PubMed Web of Science ®Google Scholar
• Garrido Gómez E, Lopez San Román A, Bermejo San José F. Idiopathic pancreatitis in inflammatory bowel disease. J Crohns Colitis. 2008;2:237–40.
   PubMed Web of Science ®Google Scholar
• Akbulut S, Ozaslan E, Topal F, Albayrak L, Kayhan B, Efe C. Ulcerative colitis presenting as leukocytoclastic vasculitis of skin. World J Gastroenterol. 2008;14:2448–50.
   PubMed Web of Science ®Google Scholar
• Hatemi I, Hatemi G, Celik AF, Melikoglu M, Arzuhal N, Mat C, et al. Frequency of pathergy phenomenon and other features of Behçet’s syndrome among patients with inflammatory bowel disease. Clin Exp Rheumatol. 2008;26:S91–S5.
   Google Scholar
• Kobashigawa T, Okamoto H, Kato J, Shindo H, Imamura T, Iizuka BE, et al. Ulcerative colitis followed by the development of Behçet’s disease. Intern Med. 2004;43:243–7.
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Kondo Y, Yusa Y, Ejiri Y, Sato Y, Miyata M. An autopsy case of ulcerative colitis associated with Takayasu’s disease with a review of 13 Japanese cases. Gastroenterol Jpn. 1993;28:110–17.
   Google Scholar
• Oyanagi H, Ishihata R, Ishikawa H, Suzuki S, Kondo Y, Miyata M, et al. Ulcerative colitis associated with Takayasu’s disease. Intern Med. 1994;33:127–9.
   PubMed Web of Science ®Google Scholar
• Taddio A, Maschio M, Martelossi S, Barbi E, Ventura A. Crohn’s disease and Takayasu’s arteritis: an uncommon association. World J Gastroenterol. 2013;19:5933–5.
   PubMed Web of Science ®Google Scholar
• Katoh N, Kubota M, Shimojima Y, Ishii W, Matsuda M, Akamatsu T, Ikeda S. Takayasu’s arteritis in a patient with Crohn’s disease: an unexpected association during infliximab therapy. Intern Med. 2010;49:179–82.
   PubMed Web of Science ®Google Scholar
• Katsanos KH, Saougos V, Kosmidou M, Doukas M, Kamina S, Asproudis I, Tsianos EV. Sjogren’s syndrome in a patient with ulcerative colitis and primary sclerosing cholangitis: case report and review of the literature. J Crohn’s Colitis. 2009;3:200–3.
   Google Scholar
• Qanneta R, Papo M, Fontova R. Concurrent Sjögren’s syndrome in a patient with ulcerative colitis during infliximab therapy: a rare association. J Crohns Colitis. 2013;7:e327–8.
   Google Scholar
• Druschky A, Heckmann J, Engelhardt A, Neundörfer Myositis, a rare complication of Crohn disease. Fortschr Neurol Psychiatr. 1996;64:422–4.
   PubMed Web of Science ®Google Scholar
• Voigt E, Griga T, Tromm A, Henschel MG, Vorgerd M, May B. Polymyositis of the skeletal muscles as an extraintestinal complication in quiescent ulcerative colitis. Int J Colorectal Dis. 1999;14:304–7.
   PubMed Web of Science ®Google Scholar
• Leibowitz G, Eliakim R, Amir G, Rachmilewitz D. Dermatomyositis associated with Crohn’s disease. J Clin Gastroenterol. 1994;18:48–52.
   PubMed Web of Science ®Google Scholar
• Bodoki L, Nagy-Vincze M, Griger Z, Péter A, Dankó K. Anti-NXP2-positive dermatomyositis associated with ulcerative colitis and celiac disease. Orv Hetil. 2014;155:1033–8.
   PubMed Web of Science ®Google Scholar
• Moncoucy X, Hamon R, Diebold MD, Coussinet S, Pennaforte JL, Thiéfin G, Cadiot G. Systemic sclerosis and ulcerative colitis. Gastroenterol Clin Biol. 2001;25:324–5.
   PubMedGoogle Scholar
• Ohtsuka T. Combinational effect of low-dose oral corticosteroid and mizoribine for ulcerative colitis in a patient with systemic sclerosis. J Dermatol. 2010;37:71–4.
   PubMed Web of Science ®Google Scholar
• Colìa R, D’Onofrio F, Cantatore FP. Ulcerative colitis and systemic lupus erythematosus. Minerva Med. 2013;104:579–81.
   PubMed Web of Science ®Google Scholar
• Yamashita H, Ueda Y, Kawaguchi H, Suzuki A, Takahashi Y, Kaneko H, et al. Systemic lupus erythematosus complicated by Crohn’s disease: a case report and literature review. BMC Gastroenterol. 2012;12:174.
   PubMed Web of Science ®Google Scholar